Steward Partners Investment Advisory’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,212
| Closed | -$63K | – | 3514 |
|
|
2022
Q3 | $63K | Sell |
1,212
-15,172
| -93% | -$789K | ﹤0.01% | 1690 |
|
|
2022
Q2 | $406K | Buy |
16,384
+3,052
| +23% | +$75.6K | 0.01% | 931 |
|
|
2022
Q1 | $334K | Buy |
13,332
+1,699
| +15% | +$42.6K | 0.01% | 1079 |
|
|
2021
Q4 | $424K | Sell |
11,633
-11,707
| -50% | -$427K | 0.01% | 1001 |
|
|
2021
Q3 | $399K | Buy |
23,340
+13,114
| +128% | +$224K | 0.01% | 990 |
|
|
2021
Q2 | $137K | Sell |
10,226
-1,304
| -11% | -$17.5K | ﹤0.01% | 1855 |
|
|
2021
Q1 | $591K | Buy |
11,530
+7,363
| +177% | +$377K | 0.01% | 828 |
|
|
2020
Q4 | $258K | Buy |
4,167
+1,636
| +65% | +$101K | 0.01% | 967 |
|
|
2020
Q3 | $139K | Buy |
2,531
+1,628
| +180% | +$89.4K | ﹤0.01% | 1083 |
|
|
2020
Q2 | $52K | Buy |
903
+647
| +253% | +$37.3K | ﹤0.01% | 1400 |
|
|
2020
Q1 | $10K | Buy |
+256
| New | +$10K | ﹤0.01% | 1884 |
|